Literature DB >> 21281824

Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle.

Malgorzata Milkiewicz1, Emilie Roudier, Jennifer L Doyle, Anastassia Trifonova, Olivier Birot, Tara L Haas.   

Abstract

Chronic limb ischemia, a complication commonly observed in conjunction with cardiovascular disease, is characterized by insufficient neovascularization despite the up-regulation of pro-angiogenic mediators. One hypothesis is that ischemia induces inhibitory signals that circumvent the normal capillary growth response. FoxO transcription factors exert anti-proliferative and pro-apoptotic effects on many cell types. We studied the regulation of FoxO1 protein in ischemic rat skeletal muscle following iliac artery ligation and in cultured endothelial cells. We found that FoxO1 expression was increased in capillaries within ischemic muscles compared with those from rats that underwent a sham operation. This finding correlated with increased expression of p27(Kip1) and reduced expression of Cyclin D1. Phosphorylated Akt was reduced concurrently with the increase in FoxO1 protein. In skeletal muscle endothelial cells, nutrient stress as well as lack of shear stress stabilized FoxO1 protein, whereas shear stress induced FoxO1 degradation. Endogenous FoxO1 co-precipitated with the E3 ubiquitin ligase murine double minute-2 (Mdm2) in endothelial cells, and this interaction varied in direct relation to the extent of Akt and Mdm2 phosphorylation. Moreover, ischemic muscles had a decreased level of Mdm2 phosphorylation and a reduced interaction between Mdm2 and FoxO1. Our results provide novel evidence that the Akt-Mdm2 pathway acts to regulate endothelial cell FoxO1 expression and illustrate a potential mechanism underlying the pathophysiological up-regulation of FoxO1 under ischemic conditions.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281824      PMCID: PMC3069838          DOI: 10.1016/j.ajpath.2010.10.042

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  The many forks in FOXO's road.

Authors:  Hien Tran; Anne Brunet; Eric C Griffith; Michael E Greenberg
Journal:  Sci STKE       Date:  2003-03-04

Review 2.  Gene transfer as a tool to induce therapeutic vascular growth.

Authors:  Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

3.  A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.

Authors:  Shivapriya Ramaswamy; Noriaki Nakamura; Isabelle Sansal; Louise Bergeron; William R Sellers
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

4.  Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis.

Authors:  D Goukassian; A Díez-Juan; T Asahara; P Schratzberger; M Silver; T Murayama; J M Isner; V Andrés
Journal:  FASEB J       Date:  2001-09       Impact factor: 5.191

5.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.

Authors:  S Dimmeler; I Fleming; B Fisslthaler; C Hermann; R Busse; A M Zeiher
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

6.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

7.  Transcriptional up-regulation of endothelial cell matrix metalloproteinase-2 in response to extracellular cues involves GATA-2.

Authors:  Xiaoyan Han; Pamela J Boyd; Stephen Colgan; Joseph A Madri; Tara L Haas
Journal:  J Biol Chem       Date:  2003-09-25       Impact factor: 5.157

Review 8.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.

Authors:  Boudewijn M T Burgering; René H Medema
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

9.  Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity.

Authors:  Malgorzata Milkiewicz; Olga Hudlicka; Julie Verhaeg; Stuart Egginton; Margaret D Brown
Journal:  Clin Sci (Lond)       Date:  2003-10       Impact factor: 6.124

10.  Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

Authors:  Marc Schmidt; Silvia Fernandez de Mattos; Armando van der Horst; Rob Klompmaker; Geert J P L Kops; Eric W-F Lam; Boudewijn M T Burgering; René H Medema
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

View more
  23 in total

1.  Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injury.

Authors:  Lan T H Dang; Takahide Aburatani; Graham A Marsh; Bryce G Johnson; Stella Alimperti; Christine J Yoon; Angela Huang; Suzanne Szak; Naoki Nakagawa; Ivan Gomez; Shuyu Ren; Sarah K Read; Chris Sparages; Alfred C Aplin; Roberto F Nicosia; Chris Chen; Giovanni Ligresti; Jeremy S Duffield
Journal:  Biomaterials       Date:  2017-07-07       Impact factor: 12.479

2.  Forkhead BoxO transcription factors restrain exercise-induced angiogenesis.

Authors:  Dara Slopack; Emilie Roudier; Sammy T K Liu; Emmanuel Nwadozi; Olivier Birot; Tara L Haas
Journal:  J Physiol       Date:  2014-07-25       Impact factor: 5.182

Review 3.  FoxO3a and disease progression.

Authors:  Richard Seonghun Nho; Polla Hergert
Journal:  World J Biol Chem       Date:  2014-08-26

4.  Synergistic Regulation of Angiogenic Sprouting by Biochemical Factors and Wall Shear Stress.

Authors:  Roland Kaunas; Hojin Kang; Kayla J Bayless
Journal:  Cell Mol Bioeng       Date:  2011-12       Impact factor: 2.321

5.  PRMT1 promotes hyperglycemia in a FoxO1-dependent manner, affecting glucose metabolism, during hypobaric hypoxia exposure, in rat model.

Authors:  Susovon Bayen; Supriya Saini; Priya Gaur; Arul Joseph Duraisamy; Alpesh Kumar Sharma; Karan Pal; Praveen Vats; Shashi Bala Singh
Journal:  Endocrine       Date:  2017-11-11       Impact factor: 3.633

6.  Application of transcutaneous carbon dioxide improves capillary regression of skeletal muscle in hyperglycemia.

Authors:  Tomohiro Matsumoto; Masayuki Tanaka; Takuya Ikeji; Noriaki Maeshige; Yoshitada Sakai; Toshihiro Akisue; Hiroyo Kondo; Akihiko Ishihara; Hidemi Fujino
Journal:  J Physiol Sci       Date:  2018-11-26       Impact factor: 2.781

7.  Endothelial FoxO1 is an intrinsic regulator of thrombospondin 1 expression that restrains angiogenesis in ischemic muscle.

Authors:  Emilie Roudier; Malgorzata Milkiewicz; Olivier Birot; Dara Slopack; Andreas Montelius; Thomas Gustafsson; Ji Hye Paik; Ronald A DePinho; George P Casale; Iraklis I Pipinos; Tara L Haas
Journal:  Angiogenesis       Date:  2013-05-16       Impact factor: 9.596

8.  Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle.

Authors:  Emilie Roudier; Paul Forn; Mary Ellen Perry; Olivier Birot
Journal:  FASEB J       Date:  2012-07-26       Impact factor: 5.191

9.  FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis.

Authors:  Harita Dharaneeswaran; Md Ruhul Abid; Lei Yuan; Dylan Dupuis; David Beeler; Katherine C Spokes; Lauren Janes; Tracey Sciuto; Peter M Kang; Shou-Ching S Jaminet; Ann Dvorak; Marianne A Grant; Erzsébet Ravasz Regan; William C Aird
Journal:  Circ Res       Date:  2014-05-29       Impact factor: 17.367

10.  Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension.

Authors:  Chaosheng Deng; Dawen Wu; Minxia Yang; Yunfei Chen; Caiyun Wang; Zhanghua Zhong; Ningfang Lian; Hua Chen; Shuang Wu
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.